Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synthetic MR ABXSAT:SYNT +1.32%63 Current Ratio is 3.04 as of Mar. 2026, which is 27% below its 10-year median of 4.15. GuruFocus rates XSAT:SYNT with a GF Score™ of 63/100 and a GF Value™ of kr4.59 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 680 Healthcare Providers & Services companies, Synthetic MR AB ranks better than 77.79% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Synthetic MR AB's current ratio for the quarter that ended in Mar. 2026 was 3.04.
Synthetic MR AB has a current ratio of 3.04. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Synthetic MR AB's Current Ratio or its related term are showing as below:
XSAT:SYNT'
s Current Ratio Range Over the Past 10 Years
Min: 2.07 Med: 4.15 Max: 6.38
Current: 3.04
During the past 13 years, Synthetic MR AB's highest Current Ratio was 6.38. The lowest was 2.07. And the median was 4.15.
XSAT:SYNT's Current Ratio is ranked better than 77.79% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs XSAT:SYNT: 3.04
Synthetic MR AB (XSAT:SYNT) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Synthetic MR AB Current Ratio Related Terms
Synthetic MR AB Current Ratio Historical Data
* Premium members only.
The historical data trend for Synthetic MR AB's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:SYNT vs VEEV, BTSG, TEM: Current Ratio Comparison
For the Health Information Services subindustry, Synthetic MR AB's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synthetic MR AB Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Synthetic MR AB's Current Ratio distribution charts can be found below:
* The bar in red indicates where Synthetic MR AB's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synthetic MR AB (XSAT:SYNT) has a Current Ratio of 3.04 as of Mar. 2026. This is 27% below median its historical median of 4.15. Over the past decade, Synthetic MR AB's Current Ratio has ranged from 2.07 to 6.38. According to the industry distribution chart, Synthetic MR AB ranks #151 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 22.2%.
Is Synthetic MR AB's Current Ratio too high?
Synthetic MR AB's current Current Ratio of 3.04 is 27% below median its 10-year median of 4.15. Over the past 10 years, this metric has ranged from a low of 2.07 to a high of 6.38. The Healthcare Providers & Services industry median Current Ratio is 1.47. Synthetic MR AB's value of 3.04 is 106.8% above this industry median. Based on the distribution chart, Synthetic MR AB ranks #151 out of 680 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Synthetic MR AB has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Synthetic MR AB's Current Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Synthetic MR AB ranks #151 out of 680 companies for Current Ratio. This places Synthetic MR AB in the top 22% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.47. Synthetic MR AB's value of 3.04 is 106.8% above this benchmark. Historically, Synthetic MR AB's own Current Ratio has ranged from 2.07 to 6.38 over the past decade. While the company's 10-year median is 4.15 vs. the industry median of 1.47, Synthetic MR AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Synthetic MR AB's current Current Ratio of 3.04 is 106.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synthetic MR AB's current Current Ratio is 3.04, which is 27% below median its own 10-year median of 4.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synthetic MR AB stock overvalued right now?
Based on GuruFocus' analysis, Synthetic MR AB (XSAT:SYNT) is currently considered Possible Value Trap. The stock's GF Value™ is kr4.59, compared to a current price of kr0.62 — trading 86.6% below its estimated fair value. The current Current Ratio is 3.04, which is 27% below median its 10-year median of 4.15 and 106.8% above the Healthcare Providers & Services industry median of 1.47. Synthetic MR AB's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Synthetic MR AB (XSAT:SYNT), the current Current Ratio is 3.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Synthetic MR AB (XSAT:SYNT) Overvalued in 2026?
Based on GuruFocus' analysis, Synthetic MR AB stock appears to be undervalued.
The current stock price of kr0.62 is trading 86.6% below its estimated GF Value™ of kr4.59.
GuruFocus considers Synthetic MR AB to be Possible Value Trap.
Key valuation signals for XSAT:SYNT:
Current Ratio: 3.04 (27% below median its 10-year median of 4.15)
GF Value™: kr4.59 vs. price of kr0.62 (86.6% below fair value)
Industry Position: 106.8% above the Healthcare Providers & Services median (#151 of 680)
No single metric tells the full story. See the XSAT:SYNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Synthetic MR AB develops and markets software solutions that improve the efficiency of neuroimaging processes and diagnostic accuracy. SyntheticMR's SyMRI solution measures the brain's absolute tissue properties and generates multiple contrast-weighted images, performs automatic segmentation of biomarkers, and delivers quantitative data in a single rapid examination. Combinostics offers the AI-driven cNeuro product family, which helps clinicians make a difference in the lives of patients with neurological diseases. Geographically, the group operates in America, Europe, and APAC. The majority of its revenue is generated from Europe.
63GF Score
Get the complete analysis for XSAT:SYNT
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:SYNT has been successfully added to your 
